FDA May Amend Anticaries Monograph To Allow Combo Antiplaque Products
This article was originally published in The Tan Sheet
Executive Summary
FDA may be amenable to an oral rinse product that crosses the anticaries and antiplaque/antigingivitis monographs if studies demonstrate safety and efficacy, agency officials told Warner-Lambert at an OTC "feedback" meeting in Rockville, Md. Oct. 8.